A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

NCT01947803 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Paliperidone Palmitate

Sponsor

Xian-Janssen Pharmaceutical Ltd.